OpenResearchAlpha

Frontiers in Public Health · 18 Nov 2026

Beyond access: the evolution of Portugal’s pharmacy-based vaccination strategy and the future role of AI-driven outreach

Francisco Goiana-da-Silva, Duarte Tude-Graça, Pedro Tamudjim-Fonseca, Fabíola Costa, Fernando D. Correia, Rik Renard, João Pereira, Tomás Portas, Pedro Silva, Sónia Romano, António Teixeira Rodrigues, Nuno Cardoso, Ema Paulino, Hutan Ashrafian

0
Citations
no database records one yet
0
Citations in 2026
so far
–
Leading author's h-index
no author has a profile yet
17
References
works it cites, from open citation data

Citations by database

Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.

  • OpenCitations0
  • Crossref0

Citations per year

The current year is still counting.

  • 2026 so far0

Abstract

Vaccination programmes increasingly face a paradox: expanding access does not necessarily translate into coverage at policy targets. Portugal provides an instructive example. The integration of community pharmacies into seasonal influenza and COVID-19 vaccination created more than 3,500 vaccination points and approximately 70% of influenza doses were administered in pharmacies in 2023–2024. The pharmacy share then fell to under 46% by 2025–2026, while total influenza doses remained broadly stable (2.41 to 2.56 million per season). This indicates a redistribution of doses across settings rather than a loss of vaccination activity; changes in age eligibility, high-dose vaccination for adults aged ≥85 years in SNS units, and invitation and recall activity may all have contributed. Influenza coverage among adults aged ≥65 years remained below the World Health Organization target of 75%, at 70.5% in 2024–2025 and 73.0% in 2025–2026. This suggests that, residual under-vaccination reflects barriers beyond physical access. The authors use “activation gap” descriptively for potentially addressable interruptions between eligibility and vaccination. Portugal already uses registry-based invitations and reminders, the open question is what a conversational layer, scripted or based on generative AI, could add. Evidence is relatively strong for reminders, growing for scripted conversational interventions and preliminary for generative AI. The authors therefore propose a registry-based randomised comparison of existing recall, existing recall plus a scripted conversational intervention, and existing recall plus a generative-AI conversational intervention, with incremental vaccination, safety, equity, trust and cost per additional vaccinated person as outcomes.

What the data shows

  • No database records a citation yet, as is usual for a paper this new.

Graph

This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.

Citing paper shares an authorAuthor without a profileSize shows citations, or h-index for authors

Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.

Start with

Authors (14)

Each author's standing in QAI's scholar index: the works their ORCID iD is attached to, and for anyone whose ORCID record names a lab OpenResearch follows, their arXiv preprints matched by name and a shared co-author. Names are as printed on the paper.

ProfileMost-cited paper

Cited by 0 papers

Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.

0 shown
No citing papers for this filter.

References (17)

What it cites, from open citation data, with Crossref's record of each.